%0 Journal Article
%T The TRITON clinical trial programme: Evaluation of the PARP inhibitor rucaparib in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination deficiency (HRD)
%A Chowdhury, S.
%A Abida, W.
%A Arranz Arija, J.
%A Daugaard, G.
%A Fizazi, K.
%A Gez, E.
%A Heidenreich, A.
%A Joly Lobbedez, F.
%A McDermott, R.
%A Merseburger, A.S.
%A Piulats Rodriguez, J.M.
%A Sautois, B.
%A Sridhar, S.
%A Sternberg, C.N.
%A Watkins, S.
%A Simmons, A.
%A Shetty, S.
%A Golsorkhi, A.
%A Ryan, C.J.
%A Scher, H.
%A ,
%J Annals of Oncology
%@ 0923-7534
%D 2017-09-01
%I Elsevier BV
%~ DeepDyve